I think this is a value play. Like or leave it is your choice. I may not be as smart as BSX_declines or Pet detective or other sophisticated bashers. I believe the company buying back shares adds value longterm as they continue to introduce new products to the market.
U do not have to agree I have as much right to post here as these bashers do. I hope Ma want let to bashers intimidate her as well.
Why would anybody buy a company with declining revenues and doesn't even pay a dividend? All other major med tech companies increased revenues in 2011, and all pay a dividend, and all have larger revenues, and larger market caps. While the rest of the medical device industry is moving forward, BSX keeps swirling the bowl.